Codes / ICD10CM / M11.85

M11.85 Other specified crystal arthropathies, hip

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other specified crystal arthropathies, hip

Summary

Other specified crystal arthropathies, hip is a joint disorder affecting the hip caused by the deposition of crystals other than uric acid or calcium pyrophosphate. These crystals lead to inflammation and joint damage, often mimicking other arthritic conditions. Diagnosis relies on identifying specific crystal types in joint fluid or tissue, with a focus on the hip joint.

Causes

Other specified crystal arthropathies, hip are caused by the deposition of crystals such as calcium oxalate, cholesterol, or apatite in hip joint tissues. These crystals can form due to metabolic imbalances, genetic factors, or underlying systemic conditions. The exact mechanism varies by crystal type but involves crystal-induced inflammation.

Risk Factors

  • Metabolic disorders (e.g., hyperoxaluria, hypophosphatasia).
  • Chronic kidney disease or dialysis.
  • Genetic predisposition to crystal formation.
  • Exposure to certain medications or toxins.
  • Joint trauma or surgery affecting the hip.

Symptoms

  • Joint pain, swelling, and stiffness in the hip.
  • Warmth and redness over the affected hip.
  • Reduced range of motion in the hip.
  • Recurrent episodes of inflammation.
  • Systemic symptoms (e.g., fever) in severe cases.

Diagnosis

Diagnosis involves joint aspiration to identify crystal type via microscopy, imaging (e.g., X-rays, ultrasound) to assess hip joint damage, and clinical evaluation of symptoms. The focus is on the hip joint, with consideration of patient history and physical examination findings.

Treatment Options

Treatment may include anti-inflammatory medications to reduce pain and swelling, physical therapy to improve hip mobility, and addressing underlying metabolic or systemic conditions. In severe cases, surgical intervention may be considered to repair joint damage or remove crystals.

Prognosis and Follow-Up

Prognosis depends on the crystal type, severity of joint damage, and response to treatment. Regular follow-up is important to monitor hip function, manage symptoms, and adjust treatment as needed. Early intervention may help prevent long-term joint damage.

Complications

Potential complications include chronic hip pain, reduced mobility, joint deformity, and progression to osteoarthritis. Severe cases may lead to disability if left untreated.

Lifestyle & Prevention

Maintaining a healthy weight, avoiding joint trauma, and managing underlying conditions (e.g., metabolic disorders) may help reduce risk. Physical activity tailored to hip health and avoiding excessive stress on the joint can support prevention.

When to Seek Professional Help

Seek medical attention if hip pain is severe, persistent, or accompanied by swelling, redness, or fever. Prompt evaluation is important for accurate diagnosis and timely treatment to prevent complications.

Tips for Medical Coders

Document the specific crystal type (if identified) and the hip as the affected site. Ensure clinical documentation supports the diagnosis, including details of joint involvement, symptoms, and diagnostic findings. Code M11.85 is appropriate when the hip is the specified site of other crystal arthropathies.

Book a walkthrough

M11.85 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.